VarmX
Latest round
- Series B
Last raised
- May 2023
Total raised
- $79M
Investors
- 9
About VarmX
V.V. specializes in the development of advanced therapeutic agents for managing bleeding complications in patients using Factor Xa Direct Oral Anticoagulants (FXa-DOACs). The company was founded in 2016 in Leiden, Netherlands. Pieter Reitsma is the founder, and Jeffrey Lawson serves as the CEO.VarmX specializes in the development of VMX-C001, a universal bypassing agent designed to restore blood coagulation in patients taking Factor Xa Direct Oral Anticoagulants (FXa-DOACs). This innovative product addresses severe bleeding and mitigates surgical risks for individuals on this class of anticoagulants. VMX-C001 enables rapid treatment of severe hemorrhages, facilitating emergency surgeries with reduced bleeding risks.VarmX operates a revenue model centered around partnerships with healthcare providers, enabling the distribution of VMX-C001. The company sells directly to hospitals and clinics, integrating its product into emergency care protocols. Transactions typically involve bulk purchasing agreements, ensuring consistent availability of VMX-C001.VarmX plans to continue developing new products to enhance its portfolio in the coagulation therapeutics space, although specific release dates have not been disclosed. The company is targeting expansion into additional markets in Europe and North America, aimed at increasing access to its products.
Who invested in VarmX
9 investors across 4 rounds
See all investors in VarmX
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about VarmX
Who invested in VarmX?
VarmX has 9 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has VarmX raised?
VarmX has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did VarmX last raise money?
VarmX's most recent round on record is a Series B, in May 2023.
What does VarmX do?
VarmX is a biotechnology company.
Where is VarmX headquartered?
VarmX is headquartered in Leiden, Netherlands.
Which VCs invest in companies like VarmX?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at VarmX's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like VarmX? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.